ideal
vaccin
provid
long
last
protect
pathogen
elicit
wellround
immun
respons
engag
innat
adapt
immun
howev
limit
understand
compon
innat
immun
antibodi
cellmedi
adapt
immun
interact
function
togeth
system
level
advanc
highthroughput
omic
methodolog
becom
possibl
captur
global
chang
host
cellular
molecular
level
induc
vaccin
infect
analysi
dataset
shown
promis
discov
mechan
behind
vaccin
mediat
protect
immunolog
memori
advers
effect
well
develop
effici
antigen
adjuv
review
discuss
system
vaccinolog
take
advantag
new
technolog
platform
big
data
analysi
enabl
ration
develop
better
vaccin
vaccin
one
greatest
breakthrough
field
medicin
save
improv
human
live
tremend
scale
across
globe
yet
current
success
vaccin
develop
empir
isol
inactiv
attenu
inject
approach
even
technolog
advanc
extens
knowledg
human
immun
system
still
limit
understand
ensur
vaccin
success
develop
effect
vaccin
import
viral
pathogen
human
immunodefici
viru
hiv
influenza
dengu
virus
remain
challeng
major
hurdl
includ
identifi
earli
marker
vaccin
efficaci
advers
reaction
develop
relev
antigen
adjuv
defin
correl
protect
understand
mechan
underli
longlast
protect
immun
respons
gener
vaccin
immun
respons
vaccin
highli
complex
multifactori
greater
sum
part
involv
multilevel
interact
network
link
intracellular
biochem
signal
pathway
intercellular
commun
interorgan
cellular
traffick
space
time
interact
network
emerg
properti
immunolog
memori
protect
diseas
delin
convent
reductionist
approach
rapid
emerg
highthroughput
technolog
platform
biolog
use
systemsbas
approach
analyz
integr
larg
vari
set
omic
data
hold
promis
provid
broader
deeper
understand
complex
phenomena
system
biolog
involv
monitor
differ
compon
biolog
system
respons
specif
perturb
ii
integr
multipl
type
data
time
iii
creation
mathemat
model
predict
structur
behavior
system
question
system
vaccinolog
emerg
subdisciplin
system
biolog
aim
reconstruct
comprehens
view
organ
level
dynam
respons
vaccin
measur
multitud
omic
data
type
sampl
parallel
requir
test
valid
novel
hypothes
insight
may
aris
first
set
data
analysi
subsequ
iter
cycl
experiment
improv
predict
model
figur
follow
section
discuss
use
highthroughput
methodolog
system
vaccinolog
enabl
transit
empir
toward
ration
vaccin
design
especi
context
viral
pathogen
vaccin
x
broad
rang
cell
state
perturb
within
immun
system
compil
msigdb
collect
annot
gene
set
use
gene
set
enrich
tool
omic
approach
allow
monitor
system
chang
molecular
cellular
organ
level
respons
vaccin
infect
approach
includ
genom
proteom
metabolom
allow
studi
paramet
shown
figur
respect
box
integr
divers
system
level
dataset
use
comput
tool
mathemat
model
allow
predict
marker
protect
advers
reaction
vaccin
develop
improv
vaccin
antigen
adjuv
howev
predict
requir
valid
iter
cycl
experiment
get
conclus
evid
inclus
vaccin
formul
integr
differ
type
omic
data
give
insight
molecular
mechan
underli
vaccin
efficaci
franco
et
al
search
genet
transcript
compon
associ
magnitud
antibodi
immun
respons
influenza
vaccin
genomewid
singl
nucleotid
polymorph
genotyp
transcript
profil
abl
map
express
quantit
trait
loci
eqtl
could
import
determin
vaccin
immunogen
integr
metabolom
model
vaccin
immun
reveal
link
transcript
event
biolog
mechan
end
shuzhao
et
al
studi
respons
varicella
zoster
vaccin
zostavax
measur
transcriptom
metabolom
chang
upon
vaccin
integr
orthogon
dataset
relat
transcript
metabolit
chang
cell
popul
cytokin
level
allow
creat
tradit
map
immunodomin
b
cell
epitop
requir
identif
whole
protein
first
follow
assess
fragment
reactiv
antibodi
approach
antigen
discoveri
epitop
map
time
consum
labor
intens
expens
advanc
omic
approach
protein
microarray
map
reactiv
antibodi
cell
antigen
avail
variou
databas
relat
hostpathogen
proteinprotein
interact
tool
structur
analys
comput
capabl
theoret
predict
tremend
help
antigen
discoveri
particular
silico
analyt
predict
method
greatli
facilit
aspect
biolog
research
includ
vaccinolog
approach
revers
vaccinolog
becom
integr
part
ration
vaccin
design
involv
comput
mine
analysi
larg
dataset
relat
immun
respons
pathogen
hostpathogen
interact
host
pathogen
genom
predict
promis
antigen
candid
entail
largescal
sampl
potenti
antigen
select
base
affin
antibodi
major
histocompat
complex
mhc
molecul
experiment
valid
structur
vaccinolog
anoth
approach
facilit
ration
design
better
antigen
avail
structur
viral
protein
well
antigenantibodi
complex
made
possibl
carri
dock
model
studi
predict
b
cell
epitop
approach
use
develop
strongli
immunogen
vaccin
candid
respiratori
syncyti
viru
rsv
glycoprotein
middl
east
respiratori
syndrom
mer
viru
spike
protein
highthroughput
vitro
assay
combin
structurefunct
analys
success
use
discov
broadli
neutral
antibodi
bnab
influenza
ha
stalk
hiv
glycan
dengu
envelop
protein
structur
inform
bnabsantigen
complex
use
graft
linear
well
discontinu
hiv
epitop
comput
design
scaffold
develop
design
antigen
ngsbase
profil
antibodi
repertoir
induc
antigen
help
identif
bnab
improv
antigen
use
methodolog
improv
vaccin
candid
rsv
develop
bnab
hiv
glycoprotein
discov
combin
orthogon
dataset
relat
immun
respons
vaccin
also
yield
inform
key
antibodi
target
use
approach
lee
et
al
perform
highresolut
proteom
analysi
immunoglobulin
coupl
highthroughput
sequenc
transcript
encod
b
cell
receptor
allow
quantit
estim
antibodi
repertoir
individu
level
vaccin
trival
season
influenza
vaccin
identif
hahead
specif
broadli
protect
antibodi
comparison
b
cell
antigen
mostli
conform
cell
epitop
mostli
linear
rel
simpler
predict
paramet
requir
data
mine
base
properti
interact
mhc
protein
antigen
peptid
although
extens
divers
mhc
haplotyp
individu
level
present
major
challeng
identifi
broadli
protect
cell
epitop
compens
signific
degre
includ
frequent
present
hla
allel
across
variou
popul
epitop
predict
protocol
simplic
peptid
make
attract
target
vaccin
design
howev
cellepitop
base
design
abl
deliv
commerci
vaccin
yet
standalon
exogen
recombin
cell
antigenbas
vaccin
elicit
posit
cell
respons
unless
crosspresent
engag
limit
overcom
significantli
vaccin
base
viral
vector
dna
vaccin
use
adjuv
facilit
crosspres
dendrit
cell
recruit
furthermor
correl
cell
mediat
protect
still
well
defin
combin
b
cellmedi
immun
might
alway
need
counter
viral
pathogen
vaccinemedi
protect
gener
combin
antibodi
cellular
immun
howev
current
method
predict
vaccin
efficaci
primarili
reli
measur
antibodi
quantiti
qualiti
sever
reason
antibodi
cellular
immun
potenti
mediat
steril
immun
protect
infect
ii
vaccin
primarili
target
toward
elicit
b
cell
respons
iii
although
cell
respons
elicit
mani
vaccin
reliabl
standard
assay
predict
protect
efficaci
cellular
immun
still
avail
use
omic
methodolog
measur
system
level
chang
induc
vaccin
molecular
signatur
efficaci
predict
studi
conduct
yellow
fever
vaccin
vaccin
consist
liveattenu
strain
yellow
fever
viru
induc
neutral
antibodi
well
potent
longliv
cell
respons
use
microarray
gene
express
profil
induct
interferon
innat
antivir
gene
signatur
detect
post
vaccin
peripher
blood
mononuclear
cell
pbmc
ad
multiparamet
flow
cytometri
data
activ
innat
immun
pathway
analyz
comput
model
uniqu
gene
signatur
predict
induct
effici
cell
neutral
antibodi
respons
identifi
predict
cell
signatur
includ
express
complement
protein
eukaryot
translat
initi
factor
alpha
kinas
orchestr
integr
stress
respons
meanwhil
b
cell
growth
factor
receptor
among
gene
emerg
antibodi
respons
signatur
follow
initi
studi
system
biolog
approach
appli
studi
immun
respons
vaccin
wide
rang
pathogen
includ
influenza
viru
smallpox
hiv
studi
transcript
signatur
induc
inactiv
trival
influenza
vaccin
tiv
day
post
vaccin
reveal
marker
associ
expans
plasmablast
unfold
protein
respons
b
cell
predict
influenza
virusspecif
antibodi
respons
day
interestingli
predict
antibodi
respons
also
appear
signatur
predict
tiv
respons
critic
question
whether
univers
signatur
capabl
predict
antibodi
respons
differ
kind
vaccin
end
systemsbas
approach
use
compar
signatur
induc
differ
type
vaccin
live
attenu
influenza
vaccin
laiv
tiv
carbohydr
meningococc
vaccin
conjug
meningococc
vaccin
specif
gene
express
data
human
blood
curat
studi
express
profil
master
network
creat
blood
transcript
modul
btm
curat
studi
conclud
antibodi
respons
inactiv
vaccin
eg
season
influenza
viru
vaccin
diphtheria
toxoid
compon
conjug
meningococc
vaccin
associ
transcript
modul
relat
plasmablast
differenti
wherea
antibodi
respons
liveattenu
vaccin
eg
yellow
fever
vaccin
highli
correl
modul
involv
innat
immun
type
interferon
respons
thu
signatur
immun
may
vari
class
vaccin
immunolog
signatur
repres
broad
rang
cell
state
perturb
within
immun
system
compil
msigdb
collect
annot
gene
set
use
gene
set
enrich
tool
omic
approach
allow
monitor
system
chang
molecular
cellular
organ
level
respons
vaccin
infect
approach
includ
genom
proteom
metabolom
allow
studi
paramet
shown
figur
respect
box
integr
divers
system
level
dataset
use
comput
tool
mathemat
model
allow
predict
marker
protect
advers
reaction
vaccin
develop
improv
vaccin
antigen
adjuv
howev
predict
requir
valid
iter
cycl
experiment
get
conclus
evid
inclus
vaccin
formul
integr
differ
type
omic
data
give
insight
molecular
mechan
underli
vaccin
efficaci
franco
et
al
search
genet
transcript
compon
associ
magnitud
antibodi
immun
respons
influenza
vaccin
genomewid
singl
nucleotid
polymorph
genotyp
transcript
profil
abl
map
express
quantit
trait
loci
eqtl
could
import
determin
vaccin
immunogen
integr
metabolom
model
vaccin
immun
reveal
link
transcript
event
biolog
mechan
end
shuzhao
et
al
studi
respons
varicella
zoster
vaccin
zostavax
measur
transcriptom
metabolom
chang
upon
vaccin
integr
orthogon
dataset
relat
transcript
metabolit
chang
cell
popul
cytokin
level
allow
creat
multiscal
multifactori
respons
network
mmrn
immun
found
network
associ
inositol
phosphat
glycerophospholipid
sterol
metabol
especi
sterol
regulatori
bind
protein
key
predictor
antibodi
cell
respons
approach
broadli
applic
studi
vaccin
respons
identifi
predictor
efficaci
advers
reaction
vaccin
candid
pose
major
hurdl
regulatori
approv
although
mild
reaction
transient
fever
local
swell
inject
site
fairli
common
sever
advers
reaction
also
report
rare
instanc
fatal
viscerotrop
diseas
caus
yellow
fever
vaccin
case
case
narcolepsi
pandem
vaccine
exampl
immunolog
character
patient
viscerotrop
diseas
show
elev
level
inflammatori
monocyt
genet
background
studi
narcolept
patient
show
associ
symptom
ethnic
background
includ
genotyp
exampl
show
possibl
identifi
clinic
genet
marker
may
lead
advers
reaction
specif
vaccin
sinc
case
rare
import
appropri
clinic
infrastructur
surveil
identifi
case
follow
time
collect
sampl
analysi
order
identifi
molecular
mechan
predict
marker
sever
advers
reaction
viral
pathogen
express
pathogen
associ
molecular
pattern
pamp
detect
cellular
pattern
recognit
receptor
prr
mammalian
cell
trigger
cellular
innat
immun
respons
build
antivir
state
subsequ
lead
induct
gene
key
mediat
immun
cell
recruit
develop
adapt
immun
subunit
inactiv
vaccin
lack
viral
pamp
adjuv
critic
fulfil
requir
elicit
appropri
innat
immun
respons
open
possibl
design
ligand
stimul
specif
prr
order
get
desir
type
intens
adapt
immun
respons
specif
pathogen
silico
design
homolog
model
molecular
dock
vitro
screen
approach
use
develop
ligand
toll
like
receptor
tlr
enhanc
antigen
present
cell
recruit
similarli
receptor
antagonist
develop
enhanc
cell
antibodi
respons
agonist
activ
natur
killer
cell
current
understand
adjuv
function
induc
control
inflamm
recruit
antigen
present
cell
howev
detail
lead
specif
type
adapt
immun
complet
understood
exampl
commonli
use
adjuv
alum
molecular
event
lead
enhanc
immun
respons
still
clear
although
inflammasom
implic
alum
first
adjuv
use
licens
human
vaccin
shown
elicit
strong
antibodi
respons
coadminist
antigen
report
enhanc
divers
affin
antibodi
respons
well
longev
protect
elicit
follow
influenza
vaccin
human
effect
also
attribut
enhanc
recruit
activ
antigenpres
cell
stimul
vaccinespecif
cell
lead
induct
specif
antibodi
target
broader
neutral
epitop
comparison
transcript
profil
induc
mice
respons
alum
show
threetim
mani
gene
induc
alum
inject
site
includ
transcript
factor
jun
b
suggest
effect
type
ifn
independ
mechan
similarli
gskadjuv
contain
contain
ligand
also
shown
induc
stronger
transcript
respons
nfkb
pathway
lead
higher
express
immun
cellrecruit
chemokin
proinflammatori
cytokin
alum
transcript
profil
human
subject
respons
envelop
vaccin
adjuv
agonist
glucopyranosyl
lipid
reveal
btm
relat
innat
immun
cell
activ
earli
time
point
b
cell
activ
later
time
point
postimmun
recent
uniqu
share
transcript
profil
alum
glase
studi
use
genomewid
transcriptom
analysi
whole
blood
wb
drain
lymph
node
dln
mice
earli
time
point
post
immun
larg
variat
transcript
profil
magnitud
kinet
observ
among
adjuv
alum
glase
induc
least
greatest
transcript
respons
respect
discuss
systemsbas
approach
understand
basi
adjuvant
limit
mostli
transcript
data
set
approach
extend
proteom
metabolom
data
set
obtain
individu
vaccin
without
adjuv
integr
inform
inform
optim
use
exist
vaccin
adjuv
well
develop
ration
engin
adjuv
human
vaccin
advanc
omic
methodolog
possibl
obtain
global
readout
cellular
molecular
event
lead
comprehens
understand
immun
respons
vaccin
pathogen
systemslevel
understand
vaccineinduc
immun
requir
integr
increasingli
access
vari
data
type
requir
continu
effort
toward
develop
open
access
comput
tool
epitop
predict
databas
relat
hostpathogen
interact
omic
data
analys
sever
select
onlin
resourc
relat
subject
list
tabl
furthermor
crucial
standard
technolog
platform
data
acquisit
analysi
methodolog
improv
reproduc
omic
data
allow
interlab
comparison
manag
standard
omic
dataset
easi
access
scientif
commun
enabl
better
integr
metaanalysi
critic
furthermor
system
analysi
mostli
use
gener
hypothes
requir
valid
relev
vitro
vivo
model
subsequ
clinic
studi
success
discoveri
use
molecular
signatur
protect
advers
effect
new
vaccin
save
resourc
acceler
vaccin
research
develop
reduc
length
cost
clinic
trial
lead
enhanc
pandem
epidem
prepared
far
systemslevel
analysi
immun
respons
vaccin
gener
depend
dataset
gener
pbmc
molecular
measur
serum
profil
immun
cell
popul
move
forward
addit
paramet
age
sex
ethnic
preexist
immun
diseas
diabet
obes
chronic
infect
stress
nutrit
microbiom
environment
socioeconom
factor
consid
well
paramet
system
vaccinolog
use
omic
methodolog
hold
promis
person
vaccin
develop
ie
give
right
vaccin
right
person
right
dose
right
rout
right
time
deliv
promis
realiz
full
potenti
system
vaccinolog
immunologist
virologist
comput
biologist
mathematician
must
work
togeth
move
toward
next
gener
ration
design
viral
vaccin
